Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Deborah Collyar: What's In It for Patients?

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Jan
16
Today In Oncology
Triplet Therapy Demonstrates Superior Progression-Free Survival in First-Line dMMR-MSI-H Metastatic Colorectal Cancer
Can Multimodal AI Models Predict Distant Recurrence Risk in Patients With Early Breast Cancer
HER2-Positive Gastroesophageal Cancer Zanidatamab Plus Chemotherapy Prolongs Progression-Free Survival
Improved Contralateral Breast Cancer Risk Knowledge With Personalized Counseling Tool
Machine Learning–Guided Optical Biopsy Accurately Identifies Malignant Lung Nodules Intraoperatively
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo